During the past decade, Shandong Provincial Qianfoshan Hospital conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shandong Provincial Qianfoshan Hospital" #1 sponsor was "Qianfoshan Hospital" with 8 trials, followed by "Shandong University" with 4 trials sponsored, "Qilu Hospital of Shandong University" with 3 trials sponsored, "Shandong Provincial Hospital" with 3 trials sponsored and "Yibing Wang" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shandong Provincial Qianfoshan Hospital" #1 collaborator was "Shandong Provincial Hospital" with 6 trials as a collaborator, "Qianfoshan Hospital" with 4 trials as a collaborator, "LanZhou University" with 3 trials as a collaborator, "The Second Hospital of Shandong University" with 3 trials as a collaborator and "Ankara University" with 2 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "Shandong Provincial Qianfoshan Hospital" are "Diabetic Foot" (2 trials), "Myocardial Infarction" (2 trials), "Acute Lymphoid Leukemia" (1 trials), "Acute Migraine" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Shandong Provincial Qianfoshan Hospital" in a lesser frequency.

Most popular intervention types in "Shandong Provincial Qianfoshan Hospital" are "Drug" (18 trials), "Other" (7 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Camrelizumab" (2 trials), "5fluorouracil" (1 trials), "Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)" (1 trials), "Camrelizumab plus microwave ablation" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shandong Provincial Qianfoshan Hospital" are 32 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Shandong Provincial Qianfoshan Hospital". 3 are not yet recruiting, 13 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Shandong Provincial Qianfoshan Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shandong Provincial Qianfoshan Hospital, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".